New challenges for patient access to medicines in Greece and Europe
The European Union and Greece are making the assurance of patient access to essential medicines a central priority. The goal is to create a system that guarantees citizens receive their treatments on time, without delays, and in a sustainable manner for public funds.
Challenges in the health sector are numerous, as technology evolves and patient needs are constantly increasing. For Greece, strengthening pharmaceutical policy is a critical issue, as the country seeks to combine the quality of services provided with the financial stability of the healthcare system.
At the same time, there is a need to strengthen the pharmaceutical industry in Europe. Creating a strong drug manufacturing sector within the continent is considered essential to reduce dependence on other markets and ensure the adequacy of stocks during times of crisis.
In conclusion, cooperation between European states remains the "key" to addressing supply chain problems. The Greek authorities are actively participating in this dialogue, with the aim of protecting patients' rights and upgrading the healthcare services provided to all citizens.